The effect is a reduction of potassium levels in the body, at a capacity of 1 mEq of potassium exchanged per 1 g of res… If you have not told your doctor or pharmacist about any of the above, tell them before you take Resonium A. This is when there is too much potassium in your blood. For example, the reaction: If N2O2 was an intermediate in a mechanism, this expression could be rearranged to represent the concentration of N2O2 in the overall rate law expression using algebraic manipulation: However, once again, intermediates cannot be listed as part of the overall rate law expression, though they can be included in an individual elementary reaction … The amount of Resonium A you need to take will depend upon the amount of potassium in your blood. CLINICAL PHARMACOLOGY Mechanism Of Action. Tell your doctor or pharmacist if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food store. The rate equation for a unimolecular reaction is: A unimolecular reaction may be one of several elementary reactions in a complex mechanism. You will usually be given the enema by a doctor or nurse. pregnancy, upcoming surgery, etc. In vito exchange capacity of approximately 3.1mEq [in vivo aprox..1mEq] of potassium per gram of the drug. Consumer Medicine InformationPlease read this leaflet before you start to take this medicineWhat is in this leafletThis leaflet answers some common questions about Resonium A. Resonium. Mechanism of action. Action Cation exchange resin in sodium phase. [5], Intestinal disturbances are common, including loss of appetite, nausea, vomiting, and constipation. Mechanism of action It has an in vitro exchange capacity of approximately 3.1 mmol of potassium per gram of resin. Aldosterone. Hours Creatine after Theophylline Creatinine kinase Potassium admission pnol/litre pmol/litre unit/litre mmol/litre 0 750 124 108 2.4 4 183 550 3.6 10 1210 25 1 57 933 3.9 16 1078 28 1 3.7 20 1034 31 1 123000 3.1 It is not known whether Resonium A passes into breast milk. When the resin reaches the large intestine the hydrogen ions are exchanged for free potassium ions; the resin is then eliminated in the feces. Generic Name: sodium polystyrene sulfonate Product Name: Resonium A. Resonium A is a type of medicine used to help remove excessive amounts of potassium from the blood. [4], Polystyrene sulfonates are given by mouth with a meal or rectally by retention enema. No data available. 5.2 Pharmacokinetic properties Ion exchange resins with a particle size ranging from 5 - 10 micrometres (as in Resonium A) are not absorbed from the gastro-intestinal tract and are wholly excreted in the faeces. This effectively reduces the levels of potassium in the bloodstream. Resonium A powder contains sodium polystyrene sulfonate, which is a type of medicine known as an ion-exchange resin. Mechanism of action. Absorption: Well absorbed orally Calcium Resonium contains calcium polystyrene sulfonate which contains calcium atoms. You may need urgent medical attention or hospitalisation. Site of action predominantly in the large intestine. Other side effects not listed above may occur in some consumers. Do not give oral Resonium A to newborn babies. Do not mix Resonium A with fruit juices or sorbitol. Your doctor will regularly check the potassium, calcium and magnesium levels in your blood. The cations of greatest importance in anaesthesia and intensive care are sodium, potassium, calcium, and magnesium. François Dardel and Thomas V. Arden "Ion Exchangers" in, CS1 maint: multiple names: authors list (, "Sodium Polystyrene Sulfonate Monograph for Professionals", "Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile", "Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? Your doctor or pharmacist has weighed the risks of using this medicine against the benefits they expect it will have for you. What is a Patient Information Leaflet and why is it useful? Your doctor, however, may prescribe Resonium A for another purpose. Onset: 15 min (IV) Duration: 1-2 hr (IV); 8-10 min (PO) Therapeutic range: 24-31 mEq/L. The EKG should be monitored continuously. However, in vivo the actual amount of potassium bound is closer to 1 mmol of potassium per gram. It is used in situations where the level of potassium in the blood is too high, for example, in people who are not producing urine, or in people with severe kidney failure who are … Parr and S.M. KAYEXALATE increases fecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract.Binding of potassium reduces the concentration of free potassium in the gastrointestinal lumen, resulting in a reduction of serum … Do not take a double dose to make up for the dose you have missed. Sometimes they are serious, but most of the time they are not. ).Some health conditions may make you more susceptible to the side-effects of the drug. The doctor may change the dose or stop the Resonium A depending on what the results of these blood tests are. If the serum potassium is >6.0 mmol litre −1 , constant ECG monitoring is mandatory. Sodium polystyrene sulfonate is a cation-exchange resin taken orally that is used to reduce high levels of potassium in the blood (hyperkalemia).Sodium polystyrene sulfonate removes potassium by exchanging sodium ions for potassium ions in the intestine. Macquarie Park, NSW: Sanofi-Aventis Australia Pty Ltd. January 2014. However, in vivo the actual amount of potassium bound is closer to 1 mmol of potassium per gram. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium. It is passed (with the potassium ions) with the faeces. [3] However, it is unclear if it is beneficial and there is concern about possible side effects when it is combined with sorbitol. Decrease. Decrease. Do not stop taking Resonium A, or lower the dosage, without checking with your doctor. If it needs to be stored, it should be stored for no longer than 24 hours. Your doctor, however, may prescribe Resonium A for another purpose. Do not take it if you are breastfeeding or planning to breastfeed. Do not take it if the packaging is damaged or shows signs of tampering. If you are about to be started on any new medicine, tell your doctor or pharmacist that you are taking Resonium A. It helps most people, but it may have unwanted side effects in a few people. Immediately telephone your doctor, or the Poisons Information Centre (telephone Australia 13 11 26 or New Zealand 0800 POISON or 0800 764766), or go to Accident and Emergency at your nearest hospital, if you think you or anyone else may have taken too much Resonium A. [, Resonium A Product Information (PI). Resonium A Indication Treatment of hyperkalaemia [Plasma K+ 6-7mmol/L] in the absence of ECG changes. Calcium Resonium is a type of medicine used to help remove excessive amounts of potassium from the blood. Problems with your bowel or constipation; Digoxin, a medicine used for heart problems; Thyroxine, a medicine for hypothyroidism; Lithium, a medicine which can be used to treat bipolar disorder; Antacids containing aluminum or magnesium. If it is almost time for your next dose, skip the dose you missed and take the next dose when you are meant to. Keep Resonium A in a cool, dry place where the temperature stays below 30°C. KAYEXALATE is a non-absorbed, cation exchange polymer that contains a sodium counterion. Presentation Powder form for oral or rectal use It has an in vitro exchange capacity of approximately 3.1 mmol of potassium per gram of resin. Ask your doctor or pharmacist to answer any questions you may have. Calcium resonium powder contains the active ingredient calcium polystyrene sulphonate, which is a type of medicine called an ion exchange resin. The proposed mechanism of action is that the polymer binds gliadin in the GI and protects it from enzymatic degradation limiting the formation of immunogenic peptides which trigger an immune response causing intestinal damage. [1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Mannitol causes an osmotic diuresis but the mechanism of action in tubular necrosis remains uncertain (Stahl, 1965). 5.2 PHARMACOKINETIC PROPERTIES Absorption Calcium polystyrene sulphonate binds with potassium in the gut, forming a complex that cannot be absorbed into the blood. Mechanism of Action. Ask your doctor if you have any questions about why it has been prescribed for you. Polystyrene sulfonates are a group of medications used to treat high blood potassium.